CSL Behring
Search results
- Open275.10High275.24Low272.37
- Mkt Cap132.07BP/E (TTM)34.86Div & Yield3.81 & 1.39%
- Prev. Close278.4552 Wk. Low228.6552 Wk. High312.99
Related stocks
Open | 275.10 |
High | 275.24 |
Low | 272.37 |
Mkt Cap | 132.07B |
P/E (TTM) | 34.86 |
Div & Yield | 3.81 & 1.39% |
Prev. Close | 278.45 |
52 Wk. Low | 228.65 |
52 Wk. High | 312.99 |
Related stocks
Australian biotechnology company
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 4.03B | 12.10% ▲ |
Net Income | 950.5M | 17.10% ▲ |
Diluted EPS | 16.70% ▲ |
S&P 500^GSPC | 5,099.96+51.54 (+1.02%) |
Dow 30^DJI | 38,239.66+153.86 (+0.40%) |
Nasdaq^IXIC | 15,927.90+316.14 (+2.03%) |
Bitcoin USDBTC-USD | 63,585.88+1.45% |
Ethereum USDETH-USD | 3,265.85+5.65% |
Docebo Inc.DCBO | 44.72+1.64% |